Fundz
Real-time · AI · Cross-signal

Crescita Therapeutics just moved. Here's exactly what to do next.

Who to reach, what to say, and why now — on Crescita Therapeutics, plus every contract, funding round, and exec hire that follows, each with verified, ICP-ranked contacts.

Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.

Get the full Deep Dive on Crescita Therapeutics — free.

We'll email your report. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

▶
Watch the 2-minute tour · with sound

Crescita Signs Exclusive Distribution Agreement with NanoPass Technologies Ltd. for MicronJetTM600

Jul 17, 2024•almost 2 years ago

Contract Type

agreement

LavalManufacturingBiotechnologyHealth CareCosmetics

Description

Crescita Therapeutics Inc. announced the signing of an exclusive distribution agreement with NanoPass Technologies Ltd. to launch and distribute MicronJetTM600 in the Canadian medical aesthetics market. MicronJet is an innovative intradermal injection device that offers precise and comfortable injection, enhancing Crescita's medical aesthetic portfolio.

Company Information

Company

Crescita Therapeutics

Location

Laval, Quebec, Canada

About

Crescita Therapeutics Inc. is a growth-oriented, innovation-driven Canadian commercial dermatology company with in-house R&D and manufacturing capabilities. The company offers a portfolio of high-quality, science-based non-prescription skincare products and a commercial stage prescription product. Crescita also owns multiple proprietary transdermal delivery platforms that support the development of patented formulations to facilitate the delivery of active ingredients into or through the skin.

Predictive Intelligence
Strategic

ML-powered predictions for Crescita Therapeutics's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.